Thesis work, 60 credits - Leveraging Omics Technologies in Drug Development

AstraZeneca

AstraZeneca

Gothenburg, Sweden
Posted on Apr 14, 2025

Are you passionate about research that will lead to better treatments for patients through driving scientific innovation? Do you have a background in biological sciences and thrive in team environments? If so, we would love to hear from you!

About AstraZeneca:

AstraZeneca is a global, science-led, patient-centred biopharmaceutical company focusing on discovering, developing, and commercialising prescription medicines for some of the world’s most serious diseases. But we’re more than a global leading pharmaceutical company. At AstraZeneca, we're dedicated to being a Great Place to Work and empowering employees to push the boundaries of science and fuel their entrepreneurial spirit.

About the Opportunity:

As a Thesis Worker at AstraZeneca, you’ll find an environment that’s full of unique opportunities and exciting challenges. Here, you’ll have the opportunity to pursue your areas of interest whilst equally developing a broad skillset and knowledge base to get the best out of your experience. You’ll be working on meaningful projects to make an impact and deliver real value for our patients and our business.

Thesis work description:

This master’s thesis takes advantage of rapid technological advances in large-scale omics, especially in Next Generation Sequencing (NGS) and related technologies. These advancements have revolutionized our understanding of the molecular processes underlying diseases, leading to more effective and safer personalized medicines. In this lab-based role, you will join AstraZeneca's largest European omics wet lab, applying cutting-edge transcriptomics approaches to advance the biological understanding and drug development for various immunological and inflammatory disorders.

Key Objectives:

  • Apply Transcriptomics Techniques - Utilize advanced transcriptomics methodologies to investigate the molecular underpinnings of immunological and inflammatory disorders.
  • Enhance Biological Understanding - Contribute to the biological understanding of disease mechanisms by analyzing transcriptomic data in the context of treatment responses.
  • Support Drug Development Efforts - Assist in the development and optimization of drug candidates by leveraging omics data to identify potential therapeutic targets.
  • Personalized Medicine Applications - Explore how transcriptomic insights can be translated into more effective and safer personalized treatment strategies for a variety of diseases.
  • Collaborate with Cross-Functional Teams - Work alongside interdisciplinary teams of scientists and researchers to integrate transcriptomics with other omics technologies and biological insights.

Essential Requirements:

  • Ongoing master’s studies within Bioscience

So, what’s next?

Apply today and take the chance to be part of making a difference, making connections, and gaining the tools and experience to open doors and fulfil your potential. We can´t wait to hear from you!

We welcome your application as soon as possible, but ahead of the scheduled closing date 27th April 2025. In the event that we identify suitable candidates ahead of the scheduled closing date, we reserve the right to withdraw the vacancy earlier than published.

Date Posted

03-apr.-2025

Closing Date

27-apr.-2025Our mission is to build an inclusive and equitable environment. We want people to feel they belong at AstraZeneca and Alexion, starting with our recruitment process. We welcome and consider applications from all qualified candidates, regardless of characteristics. We offer reasonable adjustments/accommodations to help all candidates to perform at their best. If you have a need for any adjustments/accommodations, please complete the section in the application form.